Recent studies show that Moderna’s Covid-19 vaccine is 94.1% effective of preventing Covid-19 as well as 100% effective of preventing severe cases.

The company now intents to apply for authorisation for their vaccine from the US Food and Drug Administration.

“We believe that we have a vaccine that is very highly efficacious. We now have the data to prove it,” Moderna’s Chief Medical Officer Tal Zaks said. “We expect to be playing a major part in turning around this pandemic.”

Moderna will become the second company after Pfizer to apply for emergency use authorisation for their Covid vaccine.

The US FDA is now expected to meet in the first half of December to review both company’s vaccines.